It seems like everyone is talking about Ozempic, but this popular weight loss drug is only one of many glucagon-like peptide-1 (GLP-1) medications establishing themselves as the cornerstone in the management of obesity
10.3390/biomedicines10030524 Summary Keywords MASLD, MASH, NAFLD, NASH, microbiome, dysbiosis, metabolic syndrome Citation Dua A, Kumari R, Singh M, Kumar R, Pradeep S, Ojesina AI and Kumar R (2025) Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): the interplay of gut microbiome, insulin resistance, and diabetes
PetitJCercueilJLoffroyRDenimalDBouilletBFourmontCet alEffect of liraglutide therapy on liver fat content in patients with inadequately controlled type 2 diabetes: the Lira-Nafld study
FAQs Can GLP1 Meds Really Cause Tooth Sensitivity
When to Adjust GLP-1 Dose Instead of Adding Laxatives Severe or persistent constipation may signal that your GLP-1 dose is too high for your current tolerance level